Neuromuscular choristoma

Changed by Joachim Feger, 6 Sep 2021

Updates to Article Attributes

Body was changed:

Neuromuscular choristomas (NMC), also known as benign triton tumoursnerve rhabdomyomas and neuromuscular or ectomesenchymal hamartomas are benign expansile peripheral nerve sheath tumours featuring a tight interconnection of skeletal muscle and nerve fibres within the endoneurial sheath. They also seem to have a precursor role in desmoid-type fibromatosis.

Epidemiology

Neuromuscular choristomas are extremely rare and are usually seen in childhood or adolescence. There is no gender predilection 1.

Associations

Neuromuscular choristoma is associated with desmoid-type fibromatosis 1-3.

Clinical presentation

Typical clinical features include signs of neuropathy or plexopathy with muscular atrophy as well as progressive pain 1,2.

Pathology

Neuromuscular choristomachoristomas are peripheral nerve tumours where skeletal muscle fibres are positioned within a nerve and its fibres 1-3.

Aetiology

Hypotheses about the aetiology of neuromuscular choristomas include the following 1,3:

  • hamartomatous overgrowth of muscle spindles
  • intraneural entrapment of skeletal muscle during embryogenesis
  • myogenic metaplasia of nerve sheath components
  • intraneural rhabdomyoma
Location

Neuromuscular choristomas have been reported in large nerves or within the plexus as the sciatic nerve and the brachial plexus. They have been also described in cranial nerves or intraorbital 1-5.

Macroscopic appearance

Macroscopically neuromuscular choristoma shows a multifascicular fusiform nerve enlargement with some nerve fascicles showing a red muscle-like appearance. Nerve stimulation causes contraction of the whole nerve in addition to the innervated muscle 1.

Microscopic appearance

Microscopically neuromuscular choristoma is characterised by disorganized fascicles of skeletal muscle intertwined with nerve fascicles or neural elements 1-4.

Immunophenotype

Immunohistochemistry stains are positive for desmin and muscle-specific actin as well as S100, and possibly epithelial membrane antigen (EMA) or β-catenin 1-3.

Genetics

Most cases of neuromuscular choristomas show a CTNNB1 mutation 1,2.

Radiographic features

MRI

Typical magnetic resonance imaging features include fusiform enlargement of the nerve with characteristics resembling skeletal musculature, as long as there is no associated desmoid tumour 1-4.

Signal characteristics
  • T1: isointense or slightly hypointense to muscle
  • T2: isointense or slightly hypointense to muscle
  • T1 C+ (Gd): mild heterogeneous contrast enhancement

Radiology report

The radiological report should include a description of the following:

  • form, location and size
  • tumour margins and transition zone
  • affected nerve/plexus and relations to adjacent neurovascular structures
  • interfascicular fat
  • associated desmoid tumour if present
  • relations to bones

Treatment and prognosis

Neuromuscular choristoma is benign and therefore does not require an overly aggressive approach. Since a trauma or surgery related stimulation of desmoid-type fibromatosis has been considered and the latter requires an aggressive management a do not touch approach has been advocated in patients in whom the diagnosis is clinically and radiologically clear 1,4.

History and etymology

Neuromuscular choristoma was first described by E Orlandi in 1895 3,4.

Differential diagnosis

Conditions whichthat may mimic the presentation and/or appearance of a neuromuscular choristoma include 1:

  • -<p><strong>Neuromuscular choristomas (NMC)</strong>, also known as<strong> b</strong><strong>enign triton tumours</strong>, <strong>nerve rhabdomyomas</strong> and <strong>neuromuscular </strong>or <strong>ectomesenchymal </strong><strong>hamartomas</strong> are benign expansile <a href="/articles/peripheral-nerve-sheath-tumours">peripheral nerve sheath tumours</a> featuring a tight interconnection of skeletal muscle and nerve fibres within the endoneurial sheath. They also seem to have a precursor role in <a href="/articles/aggressive-fibromatosis">desmoid-type fibromatosis</a>.</p><h4>Epidemiology</h4><p>Neuromuscular choristomas are extremely rare and are usually seen in childhood or adolescence. There is no gender predilection <sup>1</sup>.</p><h5>Associations</h5><p>Neuromuscular choristoma is associated with <a href="/articles/aggressive-fibromatosis">desmoid-type fibromatosis</a> <sup>1-3</sup>.</p><h4>Clinical presentation</h4><p>Typical clinical features include signs of neuropathy or plexopathy with muscular atrophy as well as progressive pain <sup>1,2</sup>.</p><h4>Pathology</h4><p>Neuromuscular choristoma are peripheral nerve tumours where skeletal muscle fibres are positioned within a nerve and its fibres <sup>1-3</sup>.</p><h5>Aetiology</h5><p>Hypotheses about the aetiology of neuromuscular choristomas include the following <sup>1,3</sup>:</p><ul>
  • +<p><strong>Neuromuscular choristomas (NMC)</strong>, also known as<strong> b</strong><strong>enign triton tumours</strong>, <strong>nerve rhabdomyomas</strong> and <strong>neuromuscular </strong>or <strong>ectomesenchymal </strong><strong>hamartomas</strong> are benign expansile <a href="/articles/peripheral-nerve-sheath-tumours">peripheral nerve sheath tumours</a> featuring a tight interconnection of skeletal muscle and nerve fibres within the endoneurial sheath. They also seem to have a precursor role in <a href="/articles/aggressive-fibromatosis">desmoid-type fibromatosis</a>.</p><h4>Epidemiology</h4><p>Neuromuscular choristomas are extremely rare and are usually seen in childhood or adolescence. There is no gender predilection <sup>1</sup>.</p><h5>Associations</h5><p>Neuromuscular choristoma is associated with <a href="/articles/aggressive-fibromatosis">desmoid-type fibromatosis</a> <sup>1-3</sup>.</p><h4>Clinical presentation</h4><p>Typical clinical features include signs of neuropathy or plexopathy with muscular atrophy as well as progressive pain <sup>1,2</sup>.</p><h4>Pathology</h4><p>Neuromuscular choristomas are peripheral nerve tumours where skeletal muscle fibres are positioned within a nerve and its fibres <sup>1-3</sup>.</p><h5>Aetiology</h5><p>Hypotheses about the aetiology of neuromuscular choristomas include the following <sup>1,3</sup>:</p><ul>
  • -</ul><h5>Location</h5><p>Neuromuscular choristomas have been reported in large nerves or within the plexus as the sciatic nerve and the brachial plexus. They have been also described in cranial nerves or intraorbital <sup>1-5</sup>.</p><h5>Macroscopic appearance</h5><p>Macroscopically neuromuscular choristoma shows a multifascicular fusiform nerve enlargement with some nerve fascicles showing a red muscle-like appearance. Nerve stimulation causes contraction of the whole nerve in addition to the innervated muscle <sup>1</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically neuromuscular choristoma is characterised by disorganized fascicles of skeletal muscle intertwined with nerve fascicles or neural elements <sup>1-4</sup>.</p><h5>Immunophenotype</h5><p>Immunohistochemistry stains are positive for <a title="Desmin" href="/articles/desmin">desmin</a> and <a title="muscle-specific actin" href="/articles/muscle-specific-actin">muscle-specific actin</a> as well as <a title="S100" href="/articles/s100">S100</a>, and possibly <a title="Epithelial membrane antigen (EMA)" href="/articles/epithelial-membrane-antigen-ema">epithelial membrane antigen (EMA)</a> or <a title="β-catenin" href="/articles/catenin">β-catenin</a> <sup>1-3</sup>.</p><h5>Genetics</h5><p>Most cases of neuromuscular choristomas show a <em>CTNNB1</em> mutation <sup>1,2</sup>.</p><h4>Radiographic features</h4><h5>MRI</h5><p>Typical magnetic resonance imaging features include fusiform enlargement of the nerve with characteristics resembling skeletal musculature, as long as there is no associated <a href="/articles/desmoid-tumour">desmoid tumour</a> <sup>1-4</sup>.</p><h6>Signal characteristics</h6><ul>
  • +</ul><h5>Location</h5><p>Neuromuscular choristomas have been reported in large nerves or within the plexus as the sciatic nerve and the brachial plexus. They have been also described in cranial nerves or intraorbital <sup>1-5</sup>.</p><h5>Macroscopic appearance</h5><p>Macroscopically neuromuscular choristoma shows a multifascicular fusiform nerve enlargement with some nerve fascicles showing a red muscle-like appearance. Nerve stimulation causes contraction of the whole nerve in addition to the innervated muscle <sup>1</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically neuromuscular choristoma is characterised by disorganized fascicles of skeletal muscle intertwined with nerve fascicles or neural elements <sup>1-4</sup>.</p><h5>Immunophenotype</h5><p><a title="Immunohistochemistry" href="/articles/immunohistochemistry">Immunohistochemistry</a> stains are positive for <a href="/articles/desmin">desmin</a> and <a href="/articles/muscle-specific-actin">muscle-specific actin</a> as well as <a href="/articles/s100">S100</a>, and possibly <a href="/articles/epithelial-membrane-antigen-ema">epithelial membrane antigen (EMA)</a> or <a href="/articles/catenin">β-catenin</a> <sup>1-3</sup>.</p><h5>Genetics</h5><p>Most cases of neuromuscular choristomas show a <em>CTNNB1</em> mutation <sup>1,2</sup>.</p><h4>Radiographic features</h4><h5>MRI</h5><p>Typical magnetic resonance imaging features include fusiform enlargement of the nerve with characteristics resembling skeletal musculature, as long as there is no associated <a href="/articles/desmoid-tumour">desmoid tumour</a> <sup>1-4</sup>.</p><h6>Signal characteristics</h6><ul>
  • -</ul><h4>Treatment and prognosis</h4><p>Neuromuscular choristoma is benign and therefore does not require an overly aggressive approach. Since a trauma or surgery related stimulation of desmoid-type fibromatosis has been considered and the latter requires an aggressive management a do not touch approach has been advocated in patients in whom the diagnosis is clinically and radiologically clear <sup>1,4</sup>.</p><h4>History and etymology</h4><p>Neuromuscular choristoma was first described by E Orlandi in 1895 <sup>3,4</sup>.</p><h4>Differential diagnosis</h4><p>Conditions which may mimic the presentation and/or appearance of a neuromuscular choristoma include <sup>1</sup>:</p><ul>
  • +</ul><h4>Treatment and prognosis</h4><p>Neuromuscular choristoma is benign and therefore does not require an overly aggressive approach. Since a trauma or surgery related stimulation of desmoid-type fibromatosis has been considered and the latter requires aggressive management a do not touch approach has been advocated in patients in whom the diagnosis is clinically and radiologically clear <sup>1,4</sup>.</p><h4>History and etymology</h4><p>Neuromuscular choristoma was first described by E Orlandi in 1895 <sup>3,4</sup>.</p><h4>Differential diagnosis</h4><p>Conditions that may mimic the presentation and/or appearance of a neuromuscular choristoma include <sup>1</sup>:</p><ul>

References changed:

  • 1. Perry A. Neuromuscular choristoma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <a href="https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020">https://publications.iarc.fr</a>
  • 2. Stone J, Prasad N, Laumonerie P et al. Recurrent Desmoid-Type Fibromatosis Associated with Underlying Neuromuscular Choristoma. J Neurosurg. 2019;131(1):175-83. <a href="https://doi.org/10.3171/2018.3.jns152935">doi:10.3171/2018.3.jns152935</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/30168738">Pubmed</a>
  • 3. Hébert-Blouin M, Scheithauer B, Amrami K, Durham S, Spinner R. Fibromatosis: A Potential Sequela of Neuromuscular Choristoma. JNS. 2012;116(2):399-408. <a href="https://doi.org/10.3171/2011.6.jns102171">doi:10.3171/2011.6.jns102171</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21819193">Pubmed</a>
  • 4. Lam S, Grandhi R, Wong R, Hamilton R, Greene S. Neuromuscular Hamartoma of the Sciatic Nerve: Case Report and Review of the Literature. Surg Neurol Int. 2013;4(1):8. <a href="https://doi.org/10.4103/2152-7806.106266">doi:10.4103/2152-7806.106266</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/23493803">Pubmed</a>
  • 5. Castro D, Raghuram K, Phillips C. Benign Triton Tumor of the Trigeminal Nerve. AJNR Am J Neuroradiol. 2005;26(4):967-9. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977105">PMC7977105</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/15814954">Pubmed</a>
  • 1. W.H.O. Classification WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Soft Tissue and Bone Tumours. (2020) <a href="https://books.google.co.uk/books?vid=ISBN9789283245025">ISBN: 9789283245025</a><span class="ref_v4"></span>
  • 2. Stone JJ, Prasad NK, Laumonerie P, Howe BM, Amrami KK, Carter JM, Jentoft ME, Spinner RJ. Recurrent desmoid-type fibromatosis associated with underlying neuromuscular choristoma. (2018) Journal of neurosurgery. 131 (1): 175-183. <a href="https://doi.org/10.3171/2018.3.JNS152935">doi:10.3171/2018.3.JNS152935</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/30168738">Pubmed</a> <span class="ref_v4"></span>
  • 3. Hébert-Blouin MN, Scheithauer BW, Amrami KK, Durham SR, Spinner RJ. Fibromatosis: a potential sequela of neuromuscular choristoma. (2012) Journal of neurosurgery. 116 (2): 399-408. <a href="https://doi.org/10.3171/2011.6.JNS102171">doi:10.3171/2011.6.JNS102171</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21819193">Pubmed</a> <span class="ref_v4"></span>
  • 4. Lam S, Grandhi R, Wong R, Hamilton R, Greene S. Neuromuscular hamartoma of the sciatic nerve: Case report and review of the literature. (2013) Surgical neurology international. 4: 8. <a href="https://doi.org/10.4103/2152-7806.106266">doi:10.4103/2152-7806.106266</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/23493803">Pubmed</a> <span class="ref_v4"></span>
  • 5. Castro DE, Raghuram K, Phillips CD. Benign triton tumor of the trigeminal nerve. (2005) AJNR. American journal of neuroradiology. 26 (4): 967-9. <a href="https://www.ncbi.nlm.nih.gov/pubmed/15814954">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.